-- 
Newron Surges as Much as 38% on Agreement to Be Bought by Biotie

-- B y   M a r t h e   F o u r c a d e
-- 
2011-09-27T07:09:15Z

-- http://www.bloomberg.com/news/2011-09-27/newron-surges-as-much-as-38-on-agreement-to-be-bought-by-biotie.html
Newron Pharmaceuticals SpA (NWRN)  surged
as much as 38 percent in Swiss trading after  Biotie Therapies
Oyj (BTH1V)  agreed to buy the company in a transaction valued at 45
million euros.  To contact the editor responsible for this story:
Marthe Fourcade at 
 mfourcade@bloomberg.net  